Get Your Personalized Supplement StackSupplement Stack Quiz

Reishi Mycelium Extract; Fresh

Also known as: Reishi, Lingzhi, Mushroom of Immortality, PRI-290, red reishi, Ganoderma lucidum

Overview

Ganoderma lucidum, commonly known as Reishi or Lingzhi, is a medicinal mushroom extensively utilized in traditional Asian medicine, renowned for its potential health benefits, particularly in enhancing immune function and promoting longevity. This fungus typically grows on decomposing wood and has been a cornerstone of alternative healing practices for centuries. Modern research has identified bioactive compounds, particularly polysaccharides and triterpenes, which exhibit notable anti-inflammatory properties and may play a role in cancer management. Various consumption forms of Reishi, including powders, capsules, and teas, are readily available to cater to different preferences. Despite widespread anecdotal claims, rigorous clinical research remains essential to substantiate these benefits and determine appropriate therapeutic dosages.

Benefits

Ganoderma lucidum has demonstrated several evidence-backed benefits, particularly in cancer treatment support and immune enhancement. Meta-analyses reveal a relative risk increase of 1.50 for improved treatment responses in cancer patients receiving chemotherapy and radiotherapy alongside Reishi supplementation. Enhanced immune function is evidenced by improved T-lymphocyte and leukocyte activity. Patients with cancer who use Reishi often report an enhanced quality of life compared to those who do not. The current literature indicates moderately strong evidence for Ganoderma lucidum's therapeutic potential, especially among individuals with weakened immune systems due to illness or ongoing treatments.

How it works

Ganoderma lucidum primarily exerts its benefits through immune modulation. The active compounds, notably polysaccharides and triterpenes, enhance the functions of critical immune cells like T-lymphocytes and natural killer cells. This immunomodulatory effect contributes to inhibiting tumor progression and improves the efficacy of standard chemotherapy, positioning Reishi as a valuable adjunct in complementary cancer therapies.

Side effects

Ganoderma lucidum is generally considered safe for short-term use, typically not exceeding one year. Approximately 5% of users may report mild adverse effects such as nausea and occasional insomnia. Less frequent side effects occur in around 1-5% of users, with rare reactions documented in less than 1% of users. Individuals with compromised immune systems or autoimmune conditions should consult with healthcare providers before using Reishi due to potential negative interactions. Limited safety data exist for pregnant or breastfeeding women, necessitating medical consultation for these individuals.

Dosage

Although a definitive minimum effective dosage for Ganoderma lucidum has not been established, typical daily dosages range from 1.5 to 9 grams of dried mushroom, adjusted according to individual health status and specific research insights. Given the lack of consensus regarding dosages, caution is advised for prolonged use beyond one year. It is generally recommended to take Reishi with meals to improve absorption, as its bioavailability can differ based on the supplement form, such as powders or capsules. Safety thresholds and upper limits have not been clearly defined, thus prudent consumption is advised.

FAQs

Is Ganoderma lucidum safe?

Ganoderma lucidum is generally safe for short-term use, although long-term safety and potential drug interactions require further investigation.

When should I take Ganoderma lucidum?

Although no specific timing is recommended, it is commonly taken with meals to enhance absorption.

What benefits can I expect?

Users may experience improved immune function, quality of life enhancements, and potential anti-tumor effects, especially alongside conventional treatments.

Can Ganoderma lucidum cure diseases?

Ganoderma lucidum is not a cure but may act as a supportive therapy for health and wellness.